tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

CBOECboe Global Markets

Financials · Exchanges & Brokers · CBOE

The following description of the business should be read in conjunction with the information included elsewhere in this Annual Report on Form 10-K for the year ended December 31, 2025. 10-K, Item 1

Headquarters
Chicago, IL
Next results
around Feb 5, 2027
Compare with peers → Embed

CBOE and 9 peers, year by year

The 9 Financials companies closest to CBOE in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Financials companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
CBOE Cboe Global Markets FY2025 $4.7B+15.1%51.5%31.1%23.3%35.7%21.4%0.28
CPAY Corpay FY2025 $4.5B+13.9%-44.0%23.6%28.7%27.5%2.58
HOOD Robinhood Markets FY2025 $4.5B+51.6%--42.1%-20.6%0.00
COIN Coinbase FY2025 $7.2B+9.4%-20.0%17.6%-8.5%0.52
ARES Ares Management FY2025 $5.6B+44.2%--9.4%-12.3%-
GL Globe Life FY2025 $6.0B+3.7%--19.4%20.9%19.4%0.44
ERIE Erie Indemnity FY2025 $4.1B+7.2%-17.6%13.8%14.0%24.5%-
BRO Brown & Brown FY2025 $5.9B+22.8%--17.9%23.4%8.4%0.61
CME CME Group FY2025 $6.5B+6.4%-64.9%62.5%64.3%14.2%0.00
IBKR Interactive Brokers FY2025 $6.2B+23.4%--15.9%-18.3%-
Revenuepeer median $5.9B
Sales growthpeer median +13.9%
Operating marginpeer median 32.0%
Net marginpeer median 17.9%
FCF marginpeer median 23.4%
Return on equitypeer median 18.3%
Debt / equitypeer median 0.48

Gross margin, FY2016 to FY2025

Gross profit / revenue.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
CBOE Dec 80.6%44.7%44.0%45.5%36.6%42.2%44.0%50.8%50.6%51.5%
CPAY Dec ----------
HOOD Dec ----------
COIN Dec ----------
ARES Dec ----------
GL Dec 19.9%19.4%20.1%20.1%19.0%23.8%22.6%23.1%--
ERIE Dec ----------
BRO Dec ----------
CME Dec ----------
IBKR Dec ----------
Peer median----------

Operating margin, FY2016 to FY2025

Operating income / revenue.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
CBOE Dec 42.4%16.7%21.6%21.5%19.3%23.1%12.4%28.0%26.8%31.1%
CPAY Dec 41.2%39.3%44.8%46.5%40.7%43.8%42.2%44.1%45.0%44.0%
HOOD Dec ----------
COIN Dec ---−8.6%32.0%39.2%−84.8%−5.2%35.1%20.0%
ARES Dec ----------
GL Dec 20.0%19.8%20.2%20.3%19.1%24.0%22.7%23.2%--
ERIE Dec 18.4%17.2%14.5%14.4%13.3%12.1%13.2%15.9%17.8%17.6%
BRO Dec ----------
CME Dec 61.2%63.4%60.5%53.2%54.0%56.4%60.1%61.6%64.1%64.9%
IBKR Dec ----------
Peer median30.6%29.5%32.5%20.3%32.0%39.2%22.7%23.2%40.1%32.0%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
CBOE Dec 0.000.400.380.260.360.360.500.360.340.28
CPAY Dec 1.251.231.441.361.282.092.772.052.562.58
HOOD Dec ---------0.00
COIN Dec ----0.000.530.630.470.450.52
ARES Dec ----------
GL Dec 0.310.240.310.230.221.090.570.470.520.44
ERIE Dec 0.030.090.100.090.080.070.00---
BRO Dec 0.450.380.500.460.560.480.860.680.590.61
CME Dec -0.000.020.000.000.030.000.000.030.00
IBKR Dec 0.01---------
Peer median0.310.240.310.230.150.510.600.470.520.48

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out CBOE and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Work on CBOE in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CBOE/export.csv") into a cell.